Therapeutics, Small Molecules and Biologics, the 2018 Technology Showcase from NIHR Oxford Biomedical Research Centre, Oxford University Innovation and Oxford AHSN, will highlight the most exciting commercial opportunities and projects in this field.
The Themes include:

Small Molecule Discovery
Vaccines
Experimental medicine
Novel Modalities

Confirmed speakers include: Professor Christopher Schofield, Head of Organic Chemistry, University of Oxford; Dr Huw Jones, CEO, Chronos Therapeutics; Dr Thomas Hanke, Head of Academic Partnerships, Evotec; Professor Adrian Hill, Director of the Jenner Institute, Professor of Human Genetics, University of Oxford. Please see the full programme.

For further information, please see the Programme

Our partners for the event this year:

The NIHR Oxford Biomedical Research Centre (OxBRC) is based at the Oxford University Hospitals NHS Foundation Trust and run in partnership with the University of Oxford, funded by the National Institute for Health Research (NIHR).

The Oxford Academic Health Science Network (AHSN) is licensed by NHS England. It brings together universities, industry and the NHS to improve prosperity in our region through rapid channel innovation adoption.

Oxford University Innovation is the research and technology commercialisation company of the University of Oxford. It provides access to technology from Oxford researchers through intellectual property licensing, spinout company formation and material sales, and to academic expertise